Influenza vaccine produces protective antibodies against diverse flu strains in animals
A series of nanoparticle-based vaccines elicits protective antibodies against various strains of the influenza virus in nonhuman primates, according to work from Nicole Darricarrère and colleagues. Although more research is needed, the vaccines mark an important step toward a universal flu vaccine for humans, which has long been a major goal for infectious disease researchers. Current seasonal flu vaccines can prevent disease but often only work for a year, after which a new vaccine must be developed. This occurs because influenza viruses evolve extremely quickly, meaning that a year-old vaccine may not prepare the immune system to recognize a new ...







